Trial Profile
Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 [ANCILLARY OF 700049031]
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Aug 2023
Price :
$35
*
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Bacterial infections; Viral infections
- Focus Therapeutic Use
- Acronyms VITAL-Infection
- 13 Aug 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.
- 13 Aug 2023 Planned primary completion date changed from 1 Dec 2022 to 1 Dec 2023.
- 10 Mar 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2022.